Cargando…

Specific Patterns of Blood ILCs in Metastatic Melanoma Patients and Their Modulations in Response to Immunotherapy

SIMPLE SUMMARY: Anti-CTLA-4 and anti-PD-1 immune checkpoints inhibitors (ICI) have revolutionized the treatment of metastatic melanoma patients, leading to durable responses. However, some patients still not respond to this clinically used immunotherapies and there is a lack of biomarkers leading to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rethacker, Louise, Roelens, Marie, Bejar, Claudia, Maubec, Eve, Moins-Teisserenc, Hélène, Caignard, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004602/ https://www.ncbi.nlm.nih.gov/pubmed/33810032 http://dx.doi.org/10.3390/cancers13061446

Ejemplares similares

BRAF inhibitor resistance of melanoma cells triggers increased susceptibility to natural killer cell-mediated lysis
por: Frazao, Alexandra, et al.
Publicado: (2020)

Innate lymphoid cells: NK and cytotoxic ILC3 subsets infiltrate metastatic breast cancer lymph nodes
por: Rethacker, Louise, et al.
Publicado: (2022)

Flow cytometry for the assessment of blood tumour burden in cutaneous T‐cell lymphoma: towards a standardized approach
por: Vermeer, Maarten H., et al.
Publicado: (2022)

Phenotypic and Functional Characteristics of Blood Natural Killer Cells from Melanoma Patients at Different Clinical Stages
por: Fregni, Giulia, et al.
Publicado: (2013)

Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma
por: Mignard, Claire, et al.
Publicado: (2018)

NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer Treatment
por: Frazao, Alexandra, et al.
Publicado: (2019)

Observation on the efficacy of sublingual immunotherapy with dust mite allergen for perennial allergic rhinitis and the mechanism of action on ILCs with ILC1s and ILC2s and ILC3s
por: Tang, Guangjun, et al.
Publicado: (2022)

When unity makes strength: Combinatorial NK cell-based immunotherapies against melanoma
por: Messaoudene, Meriem, et al.
Publicado: (2014)

Characterization of the Microenvironment in Positive and Negative Sentinel Lymph Nodes from Melanoma Patients
por: Messaoudene, Meriem, et al.
Publicado: (2015)

Complications of sequential immunotherapy in metastatic melanoma
por: Bufalino, Shams, et al.
Publicado: (2015)

Lymphocyte phenotype during severe sepsis and septic shock
por: Le Dorze, M, et al.
Publicado: (2015)

Current status and perspectives in immunotherapy for metastatic melanoma
por: Marconcini, Riccardo, et al.
Publicado: (2018)

Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma
por: Nyakas, M., et al.
Publicado: (2019)

Mixed Response to Immunotherapy in Patients with Metastatic Melanoma
por: Rauwerdink, Daan Jan Willem, et al.
Publicado: (2020)

Combined Immunotherapy in Metastatic Melanoma with Unknown Primary
por: Khan, Yasir, et al.
Publicado: (2019)

Immunotherapy in the Treatment of Metastatic Melanoma: Current Knowledge and Future Directions
por: Ralli, Massimo, et al.
Publicado: (2020)

ILC
por: Stanitzki, Marcel
Publicado: (2018)

Update on the Management of Cutaneous Squamous Cell Carcinoma
por: MAUBEC, Eve
Publicado: (2020)

PD-1 Blockade on Tumor Microenvironment-Resident ILC2s Promotes TNF-α Production and Restricts Progression of Metastatic Melanoma
por: Howard, Emily, et al.
Publicado: (2021)

Severe Altered Immune Status After Burn Injury Is Associated With Bacterial Infection and Septic Shock
por: Moins-Teisserenc, Hélène, et al.
Publicado: (2021)

Modulation of the Gut Microbiome to Enhance Immunotherapy Response in Metastatic Melanoma Patients: A Clinical Review
por: Najmi, Maleka, et al.
Publicado: (2022)

Immunotherapy in metastatic melanoma: a novel scenario of new toxicities and their management
por: Simeone, Ester, et al.
Publicado: (2019)

Significance of metastatic topography for the immunotherapy of cutaneous and ocular melanomas
por: Săftescu, Sorin, et al.
Publicado: (2020)

Adoption of immunotherapy in the community for patients diagnosed with metastatic melanoma
por: Krimphove, Marieke J., et al.
Publicado: (2019)

A nano-enhanced vaccine for metastatic melanoma immunotherapy
por: Salotto, Katelyn E., et al.
Publicado: (2022)

The Tipped Balance of ILC1/ILC2 in Peripheral Blood of Oral Lichen Planus Is Related to Inflammatory Cytokines
por: Wang, Zi-Ming, et al.
Publicado: (2022)

Controversial role of ILC3s in intestinal diseases: A novelty perspective on immunotherapy
por: Zhang, Yunshu, et al.
Publicado: (2023)

Sneaky side effects and ineffectiveness of an immunotherapy with ipilimumab in a case of metastatic melanoma
por: Krecké, Nathalie, et al.
Publicado: (2016)

Physics of the ILC
por: Heinemeyer, Sven
Publicado: (2013)

The ILC detectors
por: Richard, François
Publicado: (2013)

The ILC Story
por: Kalmus, George Ernest
Publicado: (2005)

The LHC and the ILC
por: Weiglein, Georg
Publicado: (2005)

ILC-CLIC
por: Kluge, Alex
Publicado: (2009)

ILC Status
por: Asai, Shoji
Publicado: (2021)

Status of ILC
por: Stapnes, Steinar
Publicado: (2020)

Characterization of innate lymphoid cells (ILC) in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis
por: Villanova, Federica, et al.
Publicado: (2013)

Population Pharmacokinetics/Pharmacodynamics of Dabrafenib Plus Trametinib in Patients with BRAF-Mutated Metastatic Melanoma
por: Balakirouchenane, David, et al.
Publicado: (2020)

‘ILC-poiesis’: generating tissue ILCs from naïve precursors
por: Di Santo, James P., et al.
Publicado: (2017)

Transcription factor-driven regulation of ILC1 and ILC3
por: Schroeder, Jan-Hendrik, et al.
Publicado: (2022)

ILC precursors differentiate into metabolically distinct ILC1-like cells during Mycobacterium tuberculosis infection
por: Corral, Dan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s8u08nlo53a91la5b5okjeg8o2